DuPont to Showcase Overlaminate Innovations at ISA Expo in Las Vegas

22.04.25 15:06 Uhr

Werte in diesem Artikel
Aktien

53,07 EUR 0,54 EUR 1,03%

USD 0,00 USD -50,00%

Indizes

5.287,8 PKT 129,6 PKT 2,51%

DuPont de Nemours, Inc. DD announced that it would exhibit Tedlar film solutions at the International Signage Association (“ISA”) Expo in Las Vegas. The company’s Tedlar officially joined the ISA in 2025 to move forward with its commitment to bring more durable and sustainable solutions for the graphics and signage industry.Tedlar’s products have been in the market for decades, offering clear film solutions that are compatible with a wide range of adhesives, inks and laminate materials. It has incorporated innovations to now safeguard graphics against fading, graffiti, harsh cleaners, dirt and grime build-up, and mold and mildew growth. Tedlar will feature multiple film types that provide extended lifespans even in extreme outdoor environments. The brand has emerged as an ideal choice as it can be cleaned of graffiti and staining without damaging the graphic print underneath. It also protects graphics from UV light. Tedlar is safe and easy to use. The ISA Expo will enable DuPont to connect with the signage industry. DD has taken this opportunity to display innovative anti-graffiti products by collaborating with its long-time customer, General Formulations.DD stock has lost 18.5% over the past year compared with the industry’s 27.6% decline. Image Source: Zacks Investment Research DD’s Zacks Rank & Key PicksDD currently carries a Zacks Rank #3 (Hold).Some better-ranked stocks in the Basic Materials space are Akzo Nobel N.V. AKZOY, Newmont Corporation NEM and Idaho Strategic Resources, Inc. IDR. AKZOY, NEM and IDR currently carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.55 per share, implying a 10.7% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters, while missing the rest. The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $3.83 per share, indicating a 10.06% year-over-year rise. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missing it in one, with an average surprise of 34.49%. NEM’s shares have soared 46.4% in the past year.The Zacks Consensus Estimate for IDR’s 2025 earnings is pegged at 78 cents per share, indicating a rise of 16.4% from year-ago levels. IDR’s earnings beat the consensus estimate in three of the trailing four quarters while missing once, with the average surprise being roughly 77.5%.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report DuPont de Nemours, Inc. (DD): Free Stock Analysis Report Newmont Corporation (NEM): Free Stock Analysis Report Akzo Nobel NV (AKZOY): Free Stock Analysis Report Idaho Strategic Resources, Inc. (IDR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: DuPont de Nemours und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf DuPont de Nemours

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf DuPont de Nemours

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu DuPont de Nemours

Wer­bung

Analysen zu DuPont de Nemours

DatumRatingAnalyst
04.10.2021DuPont de Nemours OverweightJP Morgan Chase & Co.
20.08.2019DowDuPont OutperformCowen and Company, LLC
25.06.2019DowDuPont NeutralMonness, Crespi, Hardt & Co.
10.06.2019DowDuPont OutperformCowen and Company, LLC
06.02.2019DowDuPont Market PerformCowen and Company, LLC
DatumRatingAnalyst
04.10.2021DuPont de Nemours OverweightJP Morgan Chase & Co.
20.08.2019DowDuPont OutperformCowen and Company, LLC
10.06.2019DowDuPont OutperformCowen and Company, LLC
12.10.2018DowDuPont buyDeutsche Bank AG
29.03.2018DowDuPont OutperformBMO Capital Markets
DatumRatingAnalyst
25.06.2019DowDuPont NeutralMonness, Crespi, Hardt & Co.
06.02.2019DowDuPont Market PerformCowen and Company, LLC
12.09.2017DowDuPont NeutralMonness, Crespi, Hardt & Co.
31.05.2017Dow Chemical Market PerformCowen and Company, LLC
26.04.2017DuPont (E I DuPont de Nemours and Sector PerformRBC Capital Markets
DatumRatingAnalyst
05.01.2009Dow Chemical verkaufenEuro am Sonntag
11.04.2007Dow Chemical verkaufenHamburger Sparkasse
03.02.2006Update Rohm and Haas Co.: ReduceUBS
07.07.2005Update Rohm and Haas Co.: SellLongbow

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DuPont de Nemours nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen